tiprankstipranks
Advertisement
Advertisement

JP:4882 Stock Latest News

Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
Company AnnouncementsPerseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
2d ago
4882
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
PremiumCompany Announcements
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
2d ago
4882
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
PremiumCompany Announcements
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
2M ago
4882
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
PremiumCompany Announcements
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
2M ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
PremiumCompany Announcements
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
3M ago
4882
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
PremiumCompany AnnouncementsPerseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
3M ago
4882
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
Premium
Company Announcements
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
6M ago
4882
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
Premium
Company Announcements
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
6M ago
4882
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
PremiumCompany Announcements
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
6M ago
4882
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
PremiumCompany Announcements
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
6M ago
4882
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
PremiumCompany Announcements
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
9M ago
4882
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
PremiumCompany Announcements
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
9M ago
4882
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
PremiumCompany AnnouncementsPerseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
12M ago
4882
Perseus Proteomics Inc. Announces Change in Accounting Auditor
Premium
Company Announcements
Perseus Proteomics Inc. Announces Change in Accounting Auditor
12M ago
4882
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
Premium
Company Announcements
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
1y ago
4882
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
PremiumCompany Announcements
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
1y ago
4882
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
PremiumCompany Announcements
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
1y ago
4882
Perseus Proteomics Updates PPMX-T003 Project Details
PremiumCompany Announcements
Perseus Proteomics Updates PPMX-T003 Project Details
1y ago
4882
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
PremiumCompany Announcements
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
1y ago
4882
Perseus Proteomics Reports Financial Adjustments and Losses
PremiumCompany AnnouncementsPerseus Proteomics Reports Financial Adjustments and Losses
1y ago
4882
Perseus Proteomics Reports Increased Sales but Continued Losses
Premium
Company Announcements
Perseus Proteomics Reports Increased Sales but Continued Losses
1y ago
4882
Perseus Proteomics Extends Clinical Trial for Rare Leukemia
Premium
Company Announcements
Perseus Proteomics Extends Clinical Trial for Rare Leukemia
1y ago
4882

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >